Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other financing activities: 2024-2025

Historic Other financing activities for Kura Oncology (KURA) over the last 1 years, with Jun 2025 value amounting to $515,000.

  • Kura Oncology's Other financing activities fell 83.06% to $515,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2024, which is 613.43% up from last year.
  • Kura Oncology's Other financing activities amounted to $515,000 in Q2 2025, which was up 260.14% from $143,000 recorded in Q1 2025.
  • Kura Oncology's Other financing activities' 5-year high stood at $3.0 million during Q2 2024, with a 5-year trough of $143,000 in Q1 2025.
  • Moreover, its 2-year median value for Other financing activities was $1.5 million (2024), whereas its average is $1.5 million.
  • Data for Kura Oncology's Other financing activities shows a maximum YoY plummeted of 94.40% (in 2025) over the last 5 years.
  • Kura Oncology's Other financing activities (Quarterly) stood at $807,000 in 2024, then crashed by 83.06% to $515,000 in 2025.
  • Its Other financing activities stands at $515,000 for Q2 2025, versus $143,000 for Q1 2025 and $807,000 for Q4 2024.